AtriCure
ATRC
183 hedge funds and large institutions have $1.7B invested in AtriCure in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 45 reducing their positions, and 33 closing their positions.
286% more call options, than puts
Call options by funds: $7.5M | Put options by funds: $1.95M
69% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 45
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.49% less ownership
Funds ownership: 95.23% → 94.74% (-0.49%)
3% less funds holding
Funds holding: 188 → 183 (-5)
10% less capital invested
Capital invested by funds: $1.89B → $1.7B (-$187M)
12% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$18.2M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$17.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$15.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.2M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$12.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$29.5M |
| 2 |
PA
Perceptive Advisors
New York
|
-$13.2M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$9.69M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$6.78M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$6.09M |
ATRC Hedge Fund Activity: Q3 2020 in Review
183 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2020, worth a combined $1.7B — down 9.9% from $1.89B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of ATRC and 29 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 76 added.
The largest buyer was Fred Alger Management, adding an estimated $18.2M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $29.5M.
- 183 institutional investors held AtriCure (ATRC) as of Q3 2020, down from 188 in Q2 2020.
- Funds reported $1.7B of AtriCure stock for Q3 2020, down 9.9% quarter-over-quarter.
- 29 funds opened new AtriCure positions in Q3 2020 and 33 closed out, a net change of -4 holders.
- The largest AtriCure buyer in Q3 2020 was Fred Alger Management, an estimated $18.2M added.
- The largest AtriCure seller in Q3 2020 was Gilder Gagnon Howe & Co, an estimated $29.5M sold.
Based on aggregated 13F filings for Q3 2020.